 |
인쇄하기
취소
|
Sanofi-Synthelabo Korea Reports Financial Performance Results
Sanofi-Synthelabo Korea (currently Sanofi-Aventis after the merge between Sanofi-Synthelabo and Aventis) reported the financial performance results from last year, in which the company recorded the sales of 162.0 billion won, up 40% from the prior period.
The company's operating profit was 27.7 billion won, up 62% year-over-year, and the ordinary profit was 23.2 billion won, up 83%. The net...
The company's operating profit was 27.7 billion won, up 62% year-over-year, and the ordinary profit was 23.2 billion won, up 83%. The net...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.